Li-Mei Lin
Neurological Surgery · Tucson, AZNPI 1538296785
Payments from drug & device makers
Across 919 payments — averaging $730.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$584K
- Balt USA, LLC$24K
- Medical Device Business Services, Inc.$19K
- Rapid Medical Ltd$17K
- Medtronic$13K
- Depuy Synthes Products, Inc.$7K
- plus $7K from 9 others
Across 2 payments — averaging $1134.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rapid Medical Ltd$2K
What the payments were for
- Consulting fees$521,97080%
- Speaking & faculty fees$28,9494%
- Travel & lodging$83,86813%
- Food & beverage$17,7213%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 768 | $584,117 |
| Balt USA, LLC | 25 | $24,448 |
| Medical Device Business Services, Inc. | 10 | $19,212 |
| Rapid Medical Ltd | 19 | $17,140 |
| Medtronic | 17 | $13,016 |
| Depuy Synthes Products, Inc. | 1 | $6,975 |
| Microvention, Inc. | 7 | $3,765 |
| Johnson & Johnson | 38 | $1,220 |
| Imperative Care, Inc | 25 | $1,034 |
| Qapel Medical Inc | 3 | $328 |
| AstraZeneca | 1 | $125 |
| Scientia Vascular | 2 | $83 |
| Biosense Webster, Inc. | 1 | $78 |
| Siemens Medical Solutions USA, Inc. | 1 | $23 |
| Cordis US CORP. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SURPASS$308,240
- SURPASS EVOLVE$239,335
- COMANECI 17$16,516
- TIGERTRIEVER 17 REVASCULARIZATION DEVICE$16,516
- Pipeline$12,741
- INFINITY$10,800
- Optima Coil System$8,952
- 1488, IDEAL EYES$8,232
- TARGET$8,230
- AXS CATALYST 7$6,692
- EXCELSIOR SL-10$6,692
- NEW PRODUCT DEVELOPMENT$5,200
- CITADEL$4,000
- UNIVERSAL NEURO 3$3,438
- TREVO$2,950
- AXS INFINITY LS$2,400
- DAC$2,000
- TRANSEND$1,197
- EMBOTRAP II Revascularization Device$1,187
- NEURO$1,123
How this compares
$671,578 in reported general payments places this provider in the 90th percentile of 173 neurological surgery providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 11 | $7,675 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $125 | $7,67511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 173 neurological surgery providers in Arizona.
Other neurological surgery in Tucson
- Richard ChuaTucson$1.3M
- Julie PilitsisTucson$762K
- Paul LarsonTucson$521K
- Ryan KretzerTucson$402K
- Abhay SananTucson$229K
- Sergio RiveroTucson$226K
- Brian CallahanTucson$225K
- Travis DumontTucson$53K
- Ibrahim AlhalalTucson$53K
- Timothy PuttyTucson$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.